gadolinium dtpa has been researched along with angiotensin ii in 4 studies
| Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (angiotensin ii) | Trials (angiotensin ii) | Recent Studies (post-2010) (angiotensin ii) |
|---|---|---|---|---|---|
| 12,654 | 664 | 4,051 | 38,152 | 1,089 | 7,413 |
| Protein | Taxonomy | gadolinium dtpa (IC50) | angiotensin ii (IC50) |
|---|---|---|---|
| Atrial natriuretic peptide receptor 3 | Homo sapiens (human) | 0.002 | |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.002 | |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0018 | |
| Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0055 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.004 | |
| Type-2 angiotensin II receptor | Homo sapiens (human) | 0.0011 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boer, WH; Fransen, R; Koomans, HA; Muller, HJ; Nicolay, K | 1 |
| Lao, X; Nalcioglu, O; Roth, GM; Samoszuk, MK; Su, MY; Wang, Z | 1 |
| Berr, SS; Bishop, SP; Bove, CM; Dimaria, JM; Epstein, FH; French, BA; Gilson, WD; Kramer, CM; Scott, CD; Yang, Z | 1 |
| Adams, LC; Botnar, RM; Brangsch, J; Buchholz, R; Hamm, B; Karst, U; Kaufmann, JO; Makowski, MR; Onthank, DC; Reimann, C; Robinson, SP; Thöne-Reineke, C | 1 |
4 other study(ies) available for gadolinium dtpa and angiotensin ii
| Article | Year |
|---|---|
Contrast-enhanced dynamic magnetic resonance imaging of the rat kidney.
Topics: Angiotensin II; Animals; Contrast Media; Diuretics; Drug Combinations; Furosemide; Gadolinium; Gadolinium DTPA; Kidney; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents; Water | 1996 |
Pharmacokinetic changes induced by vasomodulators in kidneys, livers, muscles, and implanted tumors in rats as measured by dynamic Gd-DTPA-enhanced MRI.
Topics: Adenocarcinoma; Angiotensin II; Animals; Blood Flow Velocity; Capillary Permeability; Cell Transplantation; Contrast Media; Female; Gadolinium DTPA; Hydralazine; Kidney; Liver; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Mammary Neoplasms, Experimental; Muscle, Skeletal; Neoplasm Transplantation; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred F344; Vasoconstrictor Agents; Vasodilator Agents | 1996 |
The angiotensin II type 2 receptor and improved adjacent region function post-MI.
Topics: Angiotensin II; Animals; Collagen; Contrast Media; Disease Models, Animal; Gadolinium DTPA; Heart Ventricles; Image Processing, Computer-Assisted; Magnetic Resonance Imaging, Cine; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardial Contraction; Myocardial Infarction; Myocytes, Cardiac; Receptor, Angiotensin, Type 2; Stroke Volume; Systole; Ventricular Dysfunction, Left; Ventricular Remodeling | 2005 |
Concurrent Molecular Magnetic Resonance Imaging of Inflammatory Activity and Extracellular Matrix Degradation for the Prediction of Aneurysm Rupture.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Aortic Rupture; Contrast Media; Disease Models, Animal; Disease Progression; Elastin; Extracellular Matrix; Feasibility Studies; Ferrosoferric Oxide; Gadolinium DTPA; Inflammation Mediators; Magnetic Resonance Imaging; Male; Mice, Knockout, ApoE; Molecular Imaging; Predictive Value of Tests; Reproducibility of Results; Time Factors | 2019 |